Insider Trading & Ownership of Patrick G. Enright

Location: Menlo Park, CA
Summary: The estimated net worth of Patrick G. Enright is at least $172,094,301 dollars as of 05 Feb 2026. Patrick G. Enright is the Director of Vera Therapeutics, Inc. and owns shares of Vera Therapeutics, Inc. (VERA) stock worth about $102.61M. Patrick G. Enright is the Director of Zenas BioPharma, Inc. and owns shares of Zenas BioPharma, Inc. (ZBIO) stock worth about $35.07M. Patrick G. Enright is the Director of BioAge Labs, Inc. and owns shares of BioAge Labs, Inc. (BIOA) stock worth about $30.79M. Patrick G. Enright is the Director of Jazz Pharmaceuticals plc and owns shares of Jazz Pharmaceuticals plc (JAZZ) stock worth about $3.62M.
Signature: /s/ Michael Greco, Attorney-in-Fact
All Insider Reports: All Insider Reports

Follow Filing Activity

Follow Patrick G. Enright and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Quick Takeaways

Patrick G. Enright has 6 issuer positions tracked on this page.
Estimated disclosed ownership value: $172,094,301.
Recent insider filing activity is available below.

What Changed

Largest disclosed position: Vera Therapeutics, Inc. ($102,609,021).
Past-year value change for that position: +$5,527,296.

Why This Matters

This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
You can cross-check role, issuer, and filing chronology directly against the SEC source.